Email Updates

You are here

Post-CROI 2016 Webinar Series

Community Perspectives from CROI 2016
April 6, 2016

Community Perspectives from CROI 2016 offered women living with HIV capacity building and training on HIV disease and treatment advocacy. During this webinar, participants received an overview of HIV science by several speakers, including:

  • Treatment Advocacy, Kate Borloglou, Community Advisory Board, The Well Project, Community Scientific Subcommittee, AIDS Clinical Trials Group (ACTG)
  • Pre-Exposure Prophylactics Research Updates from CROI 2016, Lisa Diane White, Deputy Director, SisterLove, Inc.
  • Ring, Injectables & Cure Research Updates from CROI 2016, Jessica Salzdewel, Program Coordinator, AVAC

This webinar series was moderated by Krista Martel, Executive Director, The Well Project.

Watch the webinar.

Long-Acting Injectable Antiretrovirals for Treatment and Prevention
March 24, 2016

David Margolis (ViiV Healthcare) and Marty Markowitz (Aaron Diamond AIDS Research Center) spoke about long-acting injectable antiretrovirals for treatment and prevention.

At CROI, Margolis presented findings from the LATTE 2 trial, which tested a pair of long-acting injectables—cabotegravir (from ViiV Healthcare) and rilpivarine (from Janssen)—for HIV maintenance therapy, and Markowitz presented findings from the ÉCLAIR paste 2A study of cabotegravir in HIV-uninfected men.


Harnessing Antibodies for HIV Prevention and Treatment
March 17, 2016

John Mascola of the NIH Vaccine Research Center spoke about harnessing antibodies for HIV prevention and treatment. The recording includes discussion with webinar participants. For more background, click here to view his CROI plenary session.


Exploring Dapivirine Ring Results
March 1, 2016

In the first webinar of our post-CROI webinar series, Jared Baeten (MTN) and Zeda Rosenberg (IPM) spoke about the dapivirine ring trial results announced at the conference and fielded questions from webinar participants.